Book by 30 June 2026 and get a 10% early-bird discount on all events starting on or after 25 August 2026. To the promotion
GMP search engine – look up GMP compliance regulations and news
NMPA Announcement on Application of ICH Q2(R2) and Q14 Principles
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
China's National Medical Products Administration (NMPA) has published an announcement regarding the application of the principle of the ICH Q2(R2) Guideline on validation of analytical procedures and Q14 Guideline on analytical procedure development.
According to the announcement, applicants are required to conduct studies in accordance with the requirements of the ICH Q2(R2)/Q14 Guidelines. The Q2(R2)/Q14 Guidelines are applicable to the relevant studies starting from 24 November 24 (based on the time point of the trial record).
The statement further says that ICH Q14 provides two development approaches, and applicants may choose either the traditional approach or the enhanced approach, or they may choose to partially adopt the enhanced approach.
Applicants submitting registration applications that also address ICH Q12 should also implement the requirements of the applicable Q12 standards.
The information was published in Chinese language on 28 May 2024 on the NMPA website.
Related GMP News
03.06.2026EMA Provides an Outlook on the Product-Specific Bioequivalence Guidelines Expected in 2026
03.06.2026FDA Warning Letter: Missing Method Validation - From a QC Topic to a Market-Access Problem
28.05.2026WHO Working Document on Bioequivalence open for Public Consultation
21.05.2026LCGC Article on Analytical Procedure Lifecycle Approaches